Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Suppl Data
Right arrow Supplementary Data
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendell, J. R.
Right arrow Articles by Sommer, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendell, J. R.
Right arrow Articles by Sommer, S. S.
Related Collections
Right arrow Muscle disease
Right arrow All Genetics
Neurology 2001;57:645-650
© 2001 American Academy of Neurology
Articles

Diagnosis of Duchenne dystrophy by enhanced detection of small mutations

J. R. Mendell, MD;, C. H. Buzin, PhD;, J. Feng, MD;, J. Yan, MD;, C. Serrano, MD;, D. S. Sangani, BS;, C. Wall, RN;, T. W. Prior, PhD; and S. S. Sommer, MD, PhD

From the City of Hope National Medical Center (Drs. Buzin, Feng, Yan, and Sommer), Duarte, CA; and The Ohio State University Medical Center (Drs. Mendell, Serrano, Sangani, and Prior, and C. Wall), Columbus.

Address correspondence and reprint requests to Dr. Jerry R. Mendell, Department of Neurology, Room 453 Means Hall, The Ohio State University, Columbus, OH 43210; e-mail: mendell.1{at}osu.edu mendell.1@osu.edu

Objective:— To determine whether detection of small mutations of the dystrophin gene can be increased using an enhanced method of single-strand conformation polymorphism analysis.

Background:— Usual methods of DNA analysis for Duchenne dystrophy cannot identify mutations in one-third of cases. Muscle biopsy, with its inherent risks and added liability for patients with Duchenne dystrophy, becomes the sole method of diagnosis. Even with a tissue diagnosis of dystrophin deficiency, many families are excluded from carrier detection and prenatal diagnosis.

Methods:— Genomic DNA from a cohort of 93 patients with Duchenne dystrophy without identifiable gene mutations was screened for mutations. In each case, 22 kilobases of genomic DNA were scanned, including all 79 exons of the dystrophin gene, adjacent intronic regions, and six alternative exons 1.

Results:— Sixty-eight (73%) had small mutations, including 34 nonsense mutations, 27 microdeletions and insertions, and 7 splice site mutations. No missense mutations were found. One nonsense mutation in exon 59 was detected in four patients. Most mutations were new; 54 of 62 different small mutations have not been reported. Mutations were found throughout the gene: 24% in the first quartile, 31% in the second, 16% in the third, and 29% in the fourth.

Conclusions:— A highly sensitive single-strand conformation polymorphism method substantially increased detection of small dystrophin gene mutations and made it possible to diagnose approximately 90% of patients with Duchenne dystrophy by DNA analysis. These findings, combined with cost savings and safety issues, provide compelling reasons to consider DNA analysis as the initial diagnostic test for the suspected dystrophin-deficient patient.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. Legardinier, B. Legrand, C. Raguenes-Nicol, A. Bondon, S. Hardy, C. Tascon, E. Le Rumeur, and J.-F. Hubert
A Two-amino Acid Mutation Encountered in Duchenne Muscular Dystrophy Decreases Stability of the Rod Domain 23 (R23) Spectrin-like Repeat of Dystrophin
J. Biol. Chem., March 27, 2009; 284(13): 8822 - 8832.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. K. Bobo, A. Kenneson, K. Kolor, and M. A. Brown
Adherence to American Academy of Pediatrics Recommendations for Cardiac Care Among Female Carriers of Duchenne and Becker Muscular Dystrophy
Pediatrics, March 1, 2009; 123(3): e471 - e475.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Disset, C.F. Bourgeois, N. Benmalek, M. Claustres, J. Stevenin, and S. Tuffery-Giraud
An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements
Hum. Mol. Genet., March 15, 2006; 15(6): 999 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
T. W. Prior and S. J. Bridgeman
Experience and Strategy for the Molecular Testing of Duchenne Muscular Dystrophy
J. Mol. Diagn., August 1, 2005; 7(3): 317 - 326.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. C. Griggs and K. Bushby
Continued need for caution in the diagnosis of Duchenne muscular dystrophy
Neurology, May 10, 2005; 64(9): 1498 - 1499.
[Full Text] [PDF]

Home page
 PediatricsHome page
M. T. Stein, N. A. Tipnis, and P. Schultz
Fatigue, Decreased Interest in Play, Motor Delay, and Elevated Liver-Function Tests in a 4-Year-Old Boy
Pediatrics, November 1, 2004; 114(5/S2): 1437 - 1441.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Feng, J. Yan, C. H. Buzin, S. S. Sommer, and J. A. Towbin
Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1120 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. Muntoni
Is a muscle biopsy in Duchenne dystrophy really necessary?
Neurology, August 28, 2001; 57(4): 574 - 575.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.